GB202006376D0 - Recombinant sars-cov-2 polypeptides and uses - Google Patents

Recombinant sars-cov-2 polypeptides and uses

Info

Publication number
GB202006376D0
GB202006376D0 GBGB2006376.4A GB202006376A GB202006376D0 GB 202006376 D0 GB202006376 D0 GB 202006376D0 GB 202006376 A GB202006376 A GB 202006376A GB 202006376 D0 GB202006376 D0 GB 202006376D0
Authority
GB
United Kingdom
Prior art keywords
cov
polypeptides
recombinant sars
sars
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2006376.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Cape Town
Original Assignee
University of Cape Town
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Cape Town filed Critical University of Cape Town
Priority to GBGB2006376.4A priority Critical patent/GB202006376D0/en
Publication of GB202006376D0 publication Critical patent/GB202006376D0/en
Priority to PCT/IB2021/053641 priority patent/WO2021220246A1/en
Ceased legal-status Critical Current

Links

GBGB2006376.4A 2020-04-30 2020-04-30 Recombinant sars-cov-2 polypeptides and uses Ceased GB202006376D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2006376.4A GB202006376D0 (en) 2020-04-30 2020-04-30 Recombinant sars-cov-2 polypeptides and uses
PCT/IB2021/053641 WO2021220246A1 (en) 2020-04-30 2021-04-30 Recombinant sars-cov-2 polypeptides and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2006376.4A GB202006376D0 (en) 2020-04-30 2020-04-30 Recombinant sars-cov-2 polypeptides and uses

Publications (1)

Publication Number Publication Date
GB202006376D0 true GB202006376D0 (en) 2020-06-17

Family

ID=71080558

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2006376.4A Ceased GB202006376D0 (en) 2020-04-30 2020-04-30 Recombinant sars-cov-2 polypeptides and uses

Country Status (2)

Country Link
GB (1) GB202006376D0 (en)
WO (1) WO2021220246A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111778271A (en) * 2020-07-21 2020-10-16 梁建国 Recombinant plasmid and recombinant bacterium for expressing SARS-CoV-2N protein, construction method and application
CN113817028A (en) * 2020-09-22 2021-12-21 青岛海洋生物医药研究院 Polypeptide formulations
WO2022216895A1 (en) * 2021-04-09 2022-10-13 University Of Florida Research Foundation, Incorporated Methods, kits, and approaches for viral vaccines

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117651773A (en) 2021-05-10 2024-03-05 开普敦大学 Integrated molecules and glycoengineering of complex viral glycoproteins
WO2023101007A1 (en) * 2021-12-03 2023-06-08 株式会社 アイロムグループ Antigen-protein expression vector and utilization thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031822A1 (en) * 2014-12-08 2016-06-15 Novartis AG Cytomegalovirus antigens
US10960070B2 (en) * 2016-10-25 2021-03-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion coronavirus spike proteins and their use
GB201708866D0 (en) 2017-06-02 2017-07-19 Univ Cape Town Expression of chaperone proteins in planta for increased expression of heterologous polypeptides of interest
GB2573791A (en) 2018-05-17 2019-11-20 Univ Cape Town Stabilised superoxide dismutase (SOD) homolog gene and uses thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111778271A (en) * 2020-07-21 2020-10-16 梁建国 Recombinant plasmid and recombinant bacterium for expressing SARS-CoV-2N protein, construction method and application
CN113817028A (en) * 2020-09-22 2021-12-21 青岛海洋生物医药研究院 Polypeptide formulations
WO2022216895A1 (en) * 2021-04-09 2022-10-13 University Of Florida Research Foundation, Incorporated Methods, kits, and approaches for viral vaccines

Also Published As

Publication number Publication date
WO2021220246A1 (en) 2021-11-04

Similar Documents

Publication Publication Date Title
GB202006376D0 (en) Recombinant sars-cov-2 polypeptides and uses
IL284633A (en) Polypeptides comprising modified il-2 polypeptides and uses thereof
IL304469A (en) Reprogrammable tnpb polypeptides and use thereof
IL287781A (en) Clec12a-binding polypeptides and uses thereof
IL287782A (en) Cd33-binding polypeptides and uses thereof
GB202011652D0 (en) Polypeptide panels and uses thereof
IL288610A (en) Recombinant fap binding proteins and their use
IL280808A (en) Ox40-binding polypeptides and uses thereof
GB202007441D0 (en) Polypeptide
GB201819200D0 (en) Polypeptide and uses thereof
GB202017649D0 (en) Polypeptide
GB2603645B (en) Polypeptides having anti-senescent effects and uses thereof
EP4081241A4 (en) Regenerative polypeptides and uses thereof
GB202201001D0 (en) Polypeptide and use thereof
EP3663313A4 (en) N-terminal recombinant protein of ccr4 and usage thereof
GB202012804D0 (en) Agrin polypeptide and uses thereof
GB202019817D0 (en) Ligand-binding polypeptides and uses thereof
IL275241A (en) Engineered o-glycosylation in recombinant polypeptides and uses thereof
SG11202109015TA (en) Integrated and continuous recombinant protein manufacturing
GB202109082D0 (en) Polypeptides and uses thereof
GB202018733D0 (en) Polypeptides and uses thereof
IL304183A (en) Actinohivin variant polypeptides and related methods
IL309885A (en) Alpha-sheet polypeptides and their use
GB202100996D0 (en) Ezrin-derived peptides and uses
GB202304356D0 (en) Peptides and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)